|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/42 | (2006.01) |
| (11) | Number of the document | 3307267 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17735004.8 |
| Date of filing the European patent application | 2017-06-09 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation | 2019-07-25 |
| (86) | Number | PCT/EP2017/064206 |
| Date | 2017-06-09 |
| (87) | Number | WO 2017/212061 |
| Date | 2017-12-14 |
| (30) | Number | Date | Country code |
| PCT/EP2016/0633 | 2016-06-10 | WO |
| (72) |
MAES, Tamara, ES
MASCARO CRUSAT, Cristina, ES
ROTLLANT POZO, David, ES
|
| (73) |
Oryzon Genomics, S.A.,
Carrera de San Jérónimo 15 2nd floor, 28014 Madrid,
ES
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Išsėtinės sklerozės gydymas |
| MULTIPLE SCLEROSIS TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2023-06-05 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-06-09 |